Abstract
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.
All Keywords
【초록키워드】 pandemic, Vaccines, SARS-CoV-2 pandemic, variant, Delta, Laboratory, laboratory findings, Vaccination strategies, Effectiveness, understanding, clinical effectiveness, transmissible variants, immunological, raised, provided, imperative, the SARS-CoV-2, 【제목키워드】 COVID-19, SARS-CoV-2 variant, Keeping,
【초록키워드】 pandemic, Vaccines, SARS-CoV-2 pandemic, variant, Delta, Laboratory, laboratory findings, Vaccination strategies, Effectiveness, understanding, clinical effectiveness, transmissible variants, immunological, raised, provided, imperative, the SARS-CoV-2, 【제목키워드】 COVID-19, SARS-CoV-2 variant, Keeping,
{{{ 추상적인 }}}
SARS-CoV-2 전염병이 진화함에 따라 새로운 변종들이 계속해서 등장하고 있습니다. Delta와 같은 일부 전염성이 높은 변종도 현재 백신이 제공하는 효과에 대한 우려를 불러일으켰습니다. 보호의 면역학적 상관 관계와 실험실 발견이 임상 효과에 어떻게 대응하는지 이해하는 것은 미래의 백신 접종 전략을 형성하는 데 필수적입니다.